MedPath

Prospective Cohort Study: Whether or Not Patients Benefit From Participation Itself in Randomized-controlled Trials

Not Applicable
Conditions
Breast Cancer
Registration Number
JPRN-UMIN000020645
Lead Sponsor
SELECT BC executive committee
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
68
Inclusion Criteria

Not provided

Exclusion Criteria

(i) Women who are pregnant, nursing infants or intend to become pregnant. (ii) Overexpression of HER2 (Her2/neu, Erb B2), or the results of fluorescence in situ hybridization are positive.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Others
Secondary Outcome Measures
NameTimeMethod
Overall Survival
© Copyright 2025. All Rights Reserved by MedPath